DeDora Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$315K Sell
1,427
-2
-0.1% -$553 0.07% 106
2026
Q1
$422K Buy
1,429
+94
+7% +$27.9K 0.1% 85
2025
Q4
$365K Buy
1,335
+52
+4% +$14.1K 0.09% 95
2025
Q3
$347K Hold
1,283
0.08% 96
2025
Q2
$354K Buy
1,283
+62
+5% +$16.9K 0.09% 95
2025
Q1
$324K Buy
+1,221
New +$301K 0.09% 99
2022
Q2
Sell
-264
Closed -$63K 157
2022
Q1
$63K Buy
+264
New +$62K 0.03% 145
2020
Q3
Sell
-2,128
Closed -$346K 93
2020
Q2
$346K Sell
2,128
-2,498
-54% -$448K 0.21% 74
2020
Q1
$800K Sell
4,626
-7
-0.2% -$1.39K 0.6% 46
2019
Q4
$930K Buy
4,633
+1,444
+45% +$296K 0.56% 49
2019
Q3
$674K Buy
3,189
+1,036
+48% +$216K 0.47% 51
2019
Q2
$418K Sell
2,153
-2,285
-51% -$421K 0.29% 61
2019
Q1
$730K Buy
+4,438
New +$785K 0.55% 47

Other funds holding CME

DeDora Capital's CME Position: Q2 2026 in Review

DeDora Capital reduced its CME Group (CME) stake by 0.14% in Q2 2026, selling an estimated $553 and leaving 1,427 shares worth $315K. The position accounts for 0.07% of the portfolio, ranked #106.

DeDora Capital first reported a position in CME in Q1 2019 and has held it in 13 quarters since. The position peaked at $930K in Q4 2019. 1,701 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • DeDora Capital held 1,427 shares of CME Group worth $315K as of Q2 2026.
  • DeDora Capital sold 2 CME Group shares in Q2 2026, an estimated $553.
  • CME Group made up 0.07% of DeDora Capital's portfolio in Q2 2026, its #106 holding.
  • DeDora Capital first reported a position in CME Group in Q1 2019 and has held it in 13 quarters since.
  • DeDora Capital's CME Group position peaked at $930K in Q4 2019.
  • 1,701 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on DeDora Capital's 13F filing for Q2 2026, filed 13 Jul 2026.